(Date:12/1/2009)..., WASHINGTON, Dec. 1 In...are more likely than those with traditional covera..., to be more engaged in wellness programs, and to ...s matter in holding down costs, according to surve...ee Benefit Research Institute (EBRI). ,, At th...
(Date:12/1/2009)..., PHOENIX, Dec. 1 Abrazo Media R...nd Scoliosis ( http:// www.pedsorthopaedics.com ) ... orthopaedic surgeon Dr. J. Hunt Udall to its prac...ne and orthopaedic surgery after recently completi...n Boston, Massachusetts where he focused on adult ...
(Date:12/1/2009)..., FORT LAUDERDALE, Fla., Dec. 1 O...t enrollment in the randomized clinical trial of t...ombo Stent). ,, A prospective, randomized, mult...ion of an ablu M inal sirolimus coat ED bio- ...at up to 20 sites in Asia, Australia, Europe and S...
(Date:12/1/2009)... 1, 2009) The ADEAGies Foundation will honor The ...Award at the Gies Awards celebration to be held on...ion with the 2010 ADEA Annual Session & Exhibition...n, and Achievement recognize contributions to, and...atives. For a complete listing of Gies Award winne...
(Date:12/1/2009)... patients in California are unable to successfully... at hospitals despite recent state legislation int...a new study. , Posing as low-income uninsured pa...less than one-third of the hospitals they approach...er than those allowed under California law, accord...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2Health News:Hospital price transparancy laws in California fall short, study finds 2(Date:12/1/2009)..., , ARLINGTON, Va., Dec. 1 /PRNewswir... its newest report, The Market Outlook for Resea...appropriated to the NIH Scientific Research progra...RRA) is being earmarked for lab renovations, Chall...d research that spans multiple public and non-prof...
(Date:12/1/2009)..., , ATLANTA, Dec. 1 /PRNewswire-FirstCal...ogical medical device and cardiovascular tissue pr...guidance for 2010. ,, The Company expects total...$118.0 million and $123.0 million, which includes ...unding received from the Department of Defense in ...
(Date:12/1/2009)..., , CHICAGO, Dec. 1 A...ociety of North America (RSNA), Royal Philips Elec...al Breast Workspace, a set of solutions that provi...ity breast images at one workspot to help drive qu...o breast care, Philips will also highlight new cap...
Breaking Medicine Technology:BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4Suicide Risk With Antidepressants Falls With Age 54272 1Suicide Risk With Antidepressants Falls With Age 54272 2Suicide Risk With Antidepressants Falls With Age 54272 3Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 1HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 3HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 4...announced today at the American Diabetes Associati...ulin detemir [rDNA origin] injection) can,be used ...onse to insulin,glargine over a 24-hour period in ...rces that once-daily Levemir has a similar 24-hour...essor Allen B. King,Diabetes Care Center, Salinas,...
...ific Sessions, SAN FRANCISCO, June 7 Sanofi-aven...inding study for its new,injectable diabetes compo...e American Diabetes Association,s (ADA) 68th Annua...lifornia., The study found that AVE0010 was well ...rol versus placebo in type 2 diabetes patients,ina...
Other Medicine Technology:New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 2New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 3New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes 4New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 2New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 3New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study 4AB-180 iVAD
Safeguard
Icy
PeriVac Pericardiocentesis Kit with 7F pigtail catheter
Medicine Products: